US Stock MarketDetailed Quotes

IQV IQVIA Holdings

Watchlist
  • 197.270
  • +5.750+3.00%
Close Dec 20 16:00 ET
  • 197.400
  • +0.130+0.07%
Post 20:01 ET
35.80BMarket Cap25.92P/E (TTM)

About IQVIA Holdings Company

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Company Profile

SymbolIQV
Company NameIQVIA Holdings
Listing DateMay 9, 2013
Issue Price40.00
Founded1950
CEOMr. Ari Bousbib
MarketNYSE
Employees87000
Fiscal Year Ends12-31
Address2400 Ellis Road
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27703
Phone1-919-998-2000

Company Executives

  • Name
  • Position
  • Salary
  • Ari Bousbib
  • Chairman of the Board and Chief Executive Officer
  • 29.15M
  • Keriann Cherofsky
  • Senior Vice President, Chief Accounting Officer and Corporate Controller
  • --
  • Ronald E. Bruehlman
  • Executive Vice President and Chief Financial Officer
  • 8.56M
  • Eric M. Sherbet
  • Executive Vice President, General Counsel and Secretary
  • 3.97M
  • W. Richard Staub, III
  • President, Research and Development Solutions
  • --
  • Todd B. Sisitsky
  • Independent Director
  • --
  • James A. Fasano
  • Independent Director
  • 304.93K
  • Leslie WiMorris
  • Independent Director
  • 309.93K
  • Carol J. Burt
  • Independent Director
  • 342.43K
  • Colleen A. Goggins
  • Independent Director
  • 339.93K
  • John G. Danhakl
  • Independent Director
  • 319.93K
  • Dr. John M. Leonard, M.D.
  • Lead Independent Director
  • 367.43K
  • John P. Connaughton
  • Independent Director
  • --
  • Sheila A. Stamps
  • Independent Director
  • 314.93K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.